Glutathione IV in Kochi,
screened, consented, antioxidant-positioned. Not a bleaching service.

DermaVue Kochi runs a dermatologist-administered Glutathione IV programme led by Dr. Minu Liz Mathew (MD DVL, RealSelf-recognised) and her four MD DVL dermatologist team. Every infusion is delivered in a clinical setting on the Kochi Metro Blue Line, 100 metres from Pulinchode Metro Station, with pre-treatment liver function screening, an anaphylaxis kit on premises, and a dermatologist supervising the session. We are 18 minutes from Cochin International Airport and 12 minutes from LuLu Mall Edappally.

Three differences patients consistently notice. First, every infusion at DermaVue Kochi is administered under MD DVL dermatologist supervision, not by a beauty technician. Second, pre-treatment liver function tests and complete blood count are mandatory before the first session, with repeat LFTs every 4 to 6 sessions. Third, Glutathione IV is delivered as part of a full brightening plan that pairs IV with chemical peels, Q-switched laser toning and medical-grade topicals so the tone evenness holds longer than IV alone.

Most patients notice gradual improvement in skin tone evenness around session 4 to 6. A typical course is 6 to 8 weekly sessions followed by monthly maintenance. Individual response varies based on baseline pigmentation, UV exposure and whether you are also using complementary treatments such as chemical peels, laser toning and iron-oxide SPF 50.

Glutathione IV is safe when delivered under dermatologist supervision with proper safety screening. DermaVue Kochi requires baseline liver function tests before the first session and repeats LFTs every 4 to 6 sessions. Common transient effects include mild tenderness at the IV site and occasional mild nausea. Patients with liver disease, abnormal baseline LFTs, known glutathione hypersensitivity, active kidney disease, untreated thyroid disorders, or pregnancy and lactation are not candidates for IV, this is what the pre-treatment screening identifies.

DermaVue Kochi uses pharmaceutical-grade L-glutathione at clinical doses of 400 to 1200 mg per session, individualised based on body weight, baseline pigmentation and response. Vitamin C 500 to 1000 mg is typically co-infused to enhance the antioxidant and tyrosinase-inhibition effect. Each infusion runs over 30 to 45 minutes in a clinical setting under continuous dermatologist oversight.

Glutathione is recognised as an antioxidant and is not specifically approved as a skin lightening drug by a regulatory authority. IV use for skin tone evenness is administered at dermatologist discretion as part of dermatologist-directed cosmetic care. DermaVue Kochi is transparent about this, your dermatologist will explain the off-label nature, expected response, contraindications and the safety protocol during the consultation before any decision is made.

Baseline liver function tests and complete blood count are required before the first Glutathione IV session. Patients on hepatotoxic medications are evaluated by the dermatologist before any infusion is booked. The pregnancy and lactation status is confirmed. LFTs are then repeated every 4 to 6 sessions, and any abnormality triggers immediate reassessment. This protocol is what distinguishes dermatologist-administered IV from unmonitored drips offered elsewhere.

IV Glutathione can contribute to overall skin tone evenness and is used as one element of a combined brightening plan. For melasma specifically, the strongest evidence supports chemical peels, low-fluence Q-switched Nd:YAG laser toning, medical-grade topicals (TCC, cysteamine, niacinamide) and oral tranexamic acid after VTE screen. DermaVue dermatologists typically use Glutathione IV as a complementary treatment alongside these, not as standalone monotherapy for established melasma.

Glutathione-related improvement requires ongoing maintenance. Pigmentation is dynamic and is driven by UV exposure, hormones and ageing. Without monthly maintenance infusions and consistent iron-oxide SPF 50 photoprotection, gradual return towards baseline is expected, Kochi sits at UV Index 11 (Extreme) for 10 of 12 months a year, which accelerates pigment recurrence. This is true for all pigmentation treatments, not just Glutathione.

Patients with liver disease or abnormal baseline LFTs, known glutathione hypersensitivity, severe asthma with sulphite sensitivity, active kidney disease, untreated thyroid disorders, pregnancy or lactation, or patients on hepatotoxic medications without specialist review are not candidates for IV. The pre-treatment screening identifies all of these. For non-IV alternatives, our dermatologists discuss oral antioxidant supplementation, chemical peels, laser toning and medical-grade topical regimens.